Professional Documents
Culture Documents
Course Materials On Wounds
Course Materials On Wounds
Course Materials On Wounds
Wounds
Venous ulcers are the most common lower extremity wound type, comprising 45% to 60%
of all wounds, followed by neuropathic ulcers (15% to 25%), ischemic ulcers (10% to 20%),
and mixed ulcers (10% to 15%).
Pressure injuries (formerly termed pressure ulcers) result from tissue trauma occurring at
sites of increased mechanical force (pressure, shear, or friction).
Most commonly, pressure injuries are found on bony prominences, where force is increased
upon the adjacent tissues, particularly the sacrum and heel.
Prevalence of pressure injuries in US care facilities was estimated at 8.8% in 2015.
Pressure injuries can be classified into 4 stages of increasing depth and severity using the
National Pressure Ulcer Advisory Panel (NPUAP) staging system.
Two additional stages exist in this classification system: unstageable injuries, covered by
dead tissue or eschar that obscures the ulcer base, and deep tissue injuries, characterized by
purple discoloration and indicating unknown depth. Further, 2 additional definitions are
worth noting: medical-device–related pressure injury, which typically conforms to the shape
of the device and should be staged using the aforementioned staging system, and mucosal
membrane pressure injury, which typically also relates to medical-device use, but cannot be
staged because of the anatomy of mucosal tissues.
Prevention of pressure injuries begins with identification of at-risk patients. Immobility, the
health of the affected tissue, and tissue perfusion are all directly associated with development
of pressure injury.
Additional factors, such as nutrition, moisture, diabetes, and low albumin, may
contribute. Routine risk assessment is recommended by multiple national advisory boards.
Performance of risk assessment is recommended as an initial screening tool upon admission
to both acute- and long-term–care settings, with periodic reassessment thereafter.
Frequently used standardized risk assessment tools include the Braden and Norton scales.
Multiple interventions may prevent development of pressure injury. Frequent mobilization
and repositioning are commonly used, although limited evidence to support this practice
exists.
Pressure offloading is another common prevention tool. Several specialized mattresses are
superior to standard hospital mattresses in preventing formation of pressure injury.
Additional preventive measures include avoidance of excessive moisture or dryness and
optimization of nutrition.
Offloading of pressure from the affected site is the cornerstone of treatment for pressure
injuries. Depending on the site of the wound, this may be accomplished with a cushion,
specialized mattress, or heel-protection boots. In patients who remain largely immobile, and
particularly in those that are bed or chair bound, frequent repositioning is commonly
practiced, although there is not, at present, robust evidence that this improves healing
outcomes.
When feasible, physical therapy (PT) is appropriate to improve mobility, although its effect
on pressure injury healing specifically is not known.
Beyond measures to offload pressure, it is important to employ local wound-care measures,
including debridement.
Eschar and slough, however, should not be removed from unstageable injuries, as they
provide a natural protective barrier.
Ensuring adequate wound hydration is important. This can be accomplished with dressings,
including hydrocolloid or foam.
Nutritional supplementation is another important consideration. Supplementation of protein
has been associated with improved wound healing and is recommended by the American
College of Physicians (ACP) and the 2014 NPUAP Clinical Practice Guidelines.
Although optimal amount, timing, and formulation remain to be clarified, current general
guidelines for calorie and protein intake, respectively, are 30 to 35 kcal/kg/day and 1.25 to
1.5 grams/kg/day. One recent well-designed randomized controlled trial in malnourished
patients demonstrated increased reduction in injury area at 8 weeks with a high-calorie, high-
protein supplement, augmented with amino acids and antioxidants.
idence regarding the role of amino acids and antioxidants remains inconclusive. A general
guideline regarding vitamin supplementation is to limit use to patients with nutritional
deficiencies.
At this time, there is insufficient evidence to recommend zinc for pressure-injury healing.
Vitamin C has not been shown to improve healing.
Beyond pressure offloading, local wound care, and nutrition, many other modalities have
been investigated in pressure-injury healing. Electrical stimulation may accelerate wound
healing, whereas radiant-heat therapy, electromagnetic therapy, light therapy, and laser
therapy are not supported by current evidence.
Vacuum-assisted closure therapy, which uses negative pressure on the surface of the wound
to promote healing, has been shown to have beneficial effects with regard to treatment
response as well as healing time.
Surgical flap repair is occasionally used, although benefits are unclear, given high rates of
complications and wound recurrence following surgery.
Biological agents have been studied in a limited fashion in pressure-injury treatment.
Although low-strength evidence exists to support improved healing of Stage 3 and 4 injuries
with the use of platelet-derived growth factor, its use remains off label, and it carries a black-
box warning for increased risk of malignancy; thus, its use cannot be recommended. There is
little evidence to support the use of other biological agents.
Venous Ulcers
Venous ulcers of the leg result from chronic venous insufficiency and consequent edema.
They are the most common wound type and likely affect millions of people in the United
States at any given point in time.
Clinical course is often chronic, with prolonged healing time and significant risk for
recurrence.
Venous ulcers have a marked impact on health-related quality of life as well as significant
financial impact at both patient and societal levels, with an estimated yearly cost to US
taxpayers of $14.9 billion.
Venous ulcers typically occur in areas of dependent edema, most often the medial or lateral
malleoli or calf. Significant maceration and drainage are usually present. Pain may be present
but generally to a lesser degree than with ischemic ulcers. To manage venous ulcers,
underlying conditions that cause leg edema should be investigated and, if present, treated.
These include venous insufficiency, heart failure, cirrhosis, chronic kidney disease, and deep
vein thrombosis, among others. Review of the medication list should be undertaken, with
particular focus on calcium-channel blockers, nonsteroidal anti-inflammatory drugs
(NSAIDS), and certain oral hypoglycemics, all of which can cause leg edema.
The cornerstone of prevention and treatment of venous ulcers is control of edema. This is
accomplished via mechanical compression, which is supported by robust evidence indicating
improved healing outcomes, including shortened time to healing.
Numerous strategies to achieve reduction of edema via mechanical compression exist,
including wraps/bandages, stockings, and boots. Although there is insufficient evidence to
definitively recommend a “gold standard” strategy for reduction of edema, a number of
randomized controlled trials have investigated the comparative effectiveness of different
compression strategies. Available evidence suggests that multi-layer bandages are superior to
single-layer bandages, and that systems including an elastic component are superior to
predominantly inelastic systems, with 1 study showing a 3.5 times higher chance of complete
ulcer healing at 1 year with an elastic system.
High-compression stockings also appear effective, although often impractical when a wound
dressing is present.
Intermittent pneumatic compression (IPC) has shown somewhat promising results when
added to usual compression strategies but requires further study before it can be routinely
recommended.
Practically, a 2-layer bandage with an elastic component can be used until the ulcer has
healed, with subsequent transition to high-compression elastic stockings for maintenance of
edema control.
Local wound care is also important in management of venous ulcers. A number of dressing
types have no proven benefit vs plain nonadherent dressings. These include alginates, foam,
hydrocolloids, hydrofiber, and paraffin gauze.
Practically, an absorbent dressing, such as alginate or foam, to manage wound drainage
optimally and avoid periwound maceration, should be chosen. Once an ulcer is healing, is
superficial, and has minimal drainage, a plain nonadherent dressing can be used. There is
generally low-quality evidence that certain topical antimicrobials, particularly silver and
cadexamer iodine, may improve healing vs standard care.
These approaches can be considered, taking into account pragmatic factors including cost,
availability, ease of use, and patient preference. Various debridement strategies (autolytic,
enzymatic, biosurgical) have been assessed in randomized trials, although these are generally
of low quality and do not have follow-up to healing.
Evidence is insufficient to recommend any debridement strategy strongly, although,
practically, debridement of necrotic tissue is typically a component of venous ulcer care.
Sharp debridement can be used when slough or other devitalized material is present in the
wound bed. If this is not possible, an enzymatic debriding ointment can be used.
Several novel therapeutic options for venous ulcers exist, although most remain relatively
poorly studied. Pentoxifylline, when combined with compression treatment, leads to
increased rates of complete ulcer healing vs compression alone.
It warrants consideration as an adjunct, although patients should be monitored for
gastrointestinal side effects. Sulodexide, a naturally occurring glycosaminoglycan with
antithrombotic and fibrinolytic properties, may improve rate of wound healing when
combined with control of edema and local wound care, although lack of availability in the
United States limits its use.
Using bioengineered cellular and tissue products is supported by moderate-quality evidence,
although cost (more than $1000 per application) limits its utility to some extent.
It is best considered as an alternative management option for refractory ulcers. Systemic
antibiotics have generally been ineffective at improving healing outcomes in trials.
Given increasing issues with antibiotic resistance, their use should be confined to cases of
clinical wound infection. The following novel treatment approaches cannot be recommended
at present as a routine part of venous ulcer management owing to lack of supporting
evidence: electromagnetic therapy, flavonoids, aspirin, zinc, and therapeutic ultrasound
Neuropathic Ulcers
Neuropathic ulcers commonly occur in the feet of patients with sensory loss, often caused by
peripheral neuropathy. They are frequently found on the toes or metatarsal heads and may be
preceded by formation of callus in areas of pressure. Pain is characteristically absent.
Neuropathic ulcers frequently occur in the context of diabetes, and ulcers account for much
of the morbidity associated with this illness. Diabetes can cause both neuropathy and
ischemic disease; as a result, many ulcers have a multifactorial etiology. When a neuropathic
ulcer is diagnosed, arterial blood flow, structural foot deformity, and clinical presence of
infection should be assessed.
Active ischemia or infection will affect the plan of treatment significantly.
Strategies for addressing the underlying causative factors for neuropathic ulcers include
treating ischemia (if present) and offloading pressure.
Acutely, the foot should be completely offloaded, with total contact casting being the gold
standard method to accomplish this. For prevention, definitive footwear and custom orthotics
are often the most appropriate method of long-term management for patients who have
experienced previous neuropathic ulcers.
Insurance coverage for specialized footwear may be available for patients with diabetes.
When ongoing infection—such as cellulitis, osteomyelitis, or septic arthritis—is present,
providers should prescribe appropriate antimicrobial agents. Patients with nonhealing or
chronically infected neuropathic ulcers may consider amputation as a treatment option.
Local treatment of neuropathic ulcers involves debridement of the ulcer and callus,
which is often accomplished via sharp debridement with scissors or scalpel. Other forms of
debridement, such as mechanical or enzymatic, may be appropriate in certain circumstances
involving necrotic material; however, the efficacy of these approaches has not been proved.
There is no conclusive evidence that any particular dressing is superior to another.
Thus, the practical provider prescribes a dressing that accounts for cost, convenience, and
general wound principles. For patients exhibiting ischemic limbs in addition to neuropathic
components (mixed ulcers), treating the ulcer as an ischemic wound is generally preferred. In
patients with both intact blood flow and no infection, maintaining a moist wound
environment (hydrogel, hydrocolloid, or saline) is often an appropriate option. For patients
experiencing infection with intact blood flow, one must consider treating the infection
systemically. There is no conclusive evidence supporting the use of topical antimicrobials in
this context.
The role of advanced therapies for neuropathic ulcers remains largely inconclusive based on
published evidence. Hyperbaric oxygen therapy (HBOT) has been studied in the context of
diabetic foot ulcers, where it appears to improve wound healing in the short term but not at 1
year.
A nonstatistically significant trend toward reduced amputation has been demonstrated,
particularly in patients who are able to complete a full HBOT protocol.
Cost and availability limit its use.
Vacuum-assisted closure (VAC) therapy can potentially improve wound healing,
but its application and maintenance requires specifically trained staff. Remaining adjuvant
treatments for neuropathic ulcers are not strongly supported by evidence.
Ischemic Ulcers
Ischemic ulcers of the leg most often occur in the context of peripheral arterial disease
(PAD). They are frequently seen in patients with cardiovascular risk factors (smoking,
diabetes mellitus, hypertension, hyperlipidemia, advanced age, family history of
atherosclerotic vascular disease), and thus aggressive modification of these risk factors,
particularly in patients who already have known PAD, is the best preventive strategy.
Aspirin, for example, delays progression of PAD and reduces need for revascularization.
The characteristic symptom of PAD is distal leg pain with ambulation (intermittent
claudication [IC]). Rest pain, particularly at night, can develop as ischemia worsens. Pain
may be severe. Dependent rubor and elevation pallor are often observed. Affected limbs
appear pale, dry, and relatively hairless. When ischemic ulcers develop, they are typically
black in appearance because of necrotic tissue at the base and have well-demarcated borders.
They often occur distally, such as on the tips or dorsal surface of toes, and are
characteristically painful.
Although PAD is the most common cause of lower-limb arterial insufficiency, other causes,
both anatomic and functional, are possible. Thrombosis, embolism, and vasculitis are
examples of anatomic causes, whereas conditions such as Raynaud disease can lead to
functional obstruction. Trauma, fistulas, and aneurysms are other causes of impaired arterial
flow.
Regardless of cause, an objective test for identifying arterial insufficiency is measurement of
the ankle-brachial index (ABI). If the ABI is below 0.9, there is arterial insufficiency,
although, notably, this finding has suboptimal sensitivity, particularly in patients with
diabetes or distal lesions, so clinical suspicion with normal ABI should prompt further
investigation with Doppler ultrasound studies or angiography.
Patients with ulcers as a result of arterial insufficiency often have ABIs lower than 0.5.
Once PAD has developed, there is significant risk for progression despite medical
management. Over 5 years, approximately 7% of patients with asymptomatic PAD will
progress to IC, and approximately 21% of those with IC will experience worsening of their
symptoms (including progression to critical limb ischemia [CLI]). Estimates of the incidence
of amputation over 5 years in patients with IC vary widely, ranging from 4% to 27%; risk is
likely higher in patients with CLI.
The cornerstone of management for ischemic ulcers is reestablishment of arterial blood flow.
Several studies have investigated ischemic ulcer healing outcomes in CLI after
revascularization. All are observational and most are single-center retrospective studies. The
majority of enrolled patients have diabetes. Reported complete ulcer healing at 1 year post-
revascularization ranges from 52% to 87% and does not appear to vary based on
revascularization method (bypass vs endovascular), although only 1 study has specifically
reported this difference.
Local wound care, although important, has limited benefit for ulcer healing. A main goal is to
keep the ulcer and overlying eschar dry and protected until blood flow is reestablished. This
can be accomplished by covering the wound with dry gauze or topical films. To prevent wet
gangrene, hydrating dressings—including hydrocolloids, hydrogels, alginates, and foam—
should be avoided.
Several novel treatment options for ischemic ulcers exist. HBOT (discussed in more detail in
Neuropathic Ulcer section) is sometimes used despite limited supporting evidence. Some
retrospective studies suggest that wound healing is improved and amputation decreased with
IPC in patients with CLI; however, the quality of evidence is low.
Larvae therapy, which decreases wound bioburden, debrides nonviable tissue, and improves
wound healing by facilitating the remodeling process, is a consideration for infected wounds.
The strength of evidence to support the use of low-frequency ultrasound therapy in ischemic
ulcers is low.
B vitamins and folate have no benefit.
Conclusion
Chronic wounds are common and disproportionately affect older adults. Proper treatment
requires identification, appropriate classification of the etiology, management of underlying
contributing conditions, local therapies/dressings, and consideration of adjunctive therapies.
Both primary and secondary prevention are also important. Providers in multiple specialties
and across care settings, especially those caring for older adults, are likely to encounter
chronic wounds and thus should be comfortable with these steps for all major wound types.
Age-Related Declines in Hearing, Vision and Cognition
The ability to hear faint sounds in a quiet environment deteriorates with age. Peripheral
hearing sensitivity, as measured by the audiogram, is impaired in around a third of 61–70
year olds and almost two thirds of over-70 year olds (Davis, 1989; Cruickshanks et al.,
1998; Wilson et al., 1999). Ageing can also affect suprathreshold auditory processing.
Sensitivity to temporal fine structure is impaired in older adults, even in those with normal
audiometric thresholds (Grose and Mamo, 2010; Füllgrabe, 2013; Füllgrabe et al., 2015), as
is sensitivity to changes in the temporal envelope (Füllgrabe et al., 2015).
Vision also declines in old age. As with hearing, many of these changes are peripheral, and
other changes affect central processing. Hardening of the lens leads to presbyopia, which
makes it more difficult to focus on near objects. As well as age-related eye diseases such as
cataracts, glaucoma and macular degeneration, healthy ageing is linked to a thickening and
yellowing of the lens (Said and Weale, 1959; Ruddock, 1965). Ageing is also associated with
changes in color perception (Page and Crognale, 2005), temporal resolution (Wright and
Drasdo, 1985; Kim and Mayer, 1994; Culham and Kline, 2002), visual acuity (Spear, 1993),
motion perception (Snowden and Kavanagh, 2006; Hutchinson et al., 2012), and a loss of fine
detail (high spatial frequency) pattern vision (Elliott, 1987; Pardhan, 2004).
Deficits in one sensory modality can sometimes be offset through other senses, e.g., using
visual speechreading to support impaired hearing (Dickinson and Taylor, 2011), or increased
multisensory integration (Freiherr et al., 2013). This may be limited in older age when both
hearing and vision decline, particularly as declines in vision and audition appear to be linked,
with higher than expected rates of dual-sensory decline (Dawes et al., 2014).
Old age also brings decline in a number of cognitive abilities, including working memory,
memory, attention, and executive control (Schaie, 1996; Hedden and Gabrieli, 2004). Cross-
sectional and longitudinal studies consistently find that ageing is related to poor performance
on tasks involving cognitive control and switching, manipulation of information, visuospatial
processing, processing speed and more (for an extensive list of studies, see Hofer et al.,
2003). There are a number of proposed explanations for this decline, including generalized
slowing (e.g., Salthouse, 1996) and dedifferentiation (e.g., Wilson et al., 2012). In this brief
review, we focus on the role of sensory function.
A number of cross-sectional, population-based studies have demonstrated a link between
(auditory and visual) sensory impairment and poor cognition in old age (Lindenberger and
Baltes, 1994; Baltes and Lindenberger, 1997; Lin et al., 2004, 2011; Tay et al., 2006; Moore
et al., 2014), that does not simply reflect the visibility or audibility of the task materials
(Lindenberger et al., 2001). The association between perception and cognition is also present
in younger adults, but is stronger in older adults (Baltes and Lindenberger, 1997). While the
evidence for a link between perception and cognition is compelling, it is not universally
found. Two studies have found a link between vision and cognition but not hearing and
cognition (Anstey et al., 2001; Gussekloo et al., 2005), one study failed to find a link between
hearing and cognition (Gennis et al., 1991), and one found no link between visual or auditory
function and cognition in a narrow-age cohort sample of 75 year olds (Hofer et al., 2003).
The majority of studies that have attempted to link sensory and cognitive decline have used
only visual (or auditory) acuity as a proxy for more general perceptual decline (e.g., Anstey et
al., 2001; Hofer et al., 2003). If a common factor underlies age-related changes in
performance, then we would expect changes to also affect more central, suprathreshold
perceptual skills. However, few studies have used more higher order, cortical measures of
perception. Humes et al. (2013) used an index of temporal sensory processing and found a
clear link to performance on temporal cognitive tasks. Glass (2007) found that visual contrast
sensitivity was a better predictor of performance in cognitive tasks with unfamiliar, multiple
or complex stimuli than simple stimuli. These results suggest that going beyond simple
sensory acuity may reveal a more direct link to cognitive task performance.
Various hypotheses have been proposed to account for the link between perception and
cognition (Table 1; see Wayne and Johnsrude, 2015 for a recent review of these hypotheses
in the auditory modality). Here we consider both vision and audition as well as possible
effects of compensatory cognition.